EWMA 2013 - Ep566 - SEQUENTIAL TREATMENT OF CHRONIC WOUNDS WITH HYDRO-DESLOUGHING DRESSING* AND TLC-NOSF DRESSING*

470 views
266 views

Published on

T. SEGOVIA GÓMEZ, M. BERMEJO MARTINEZ, R. MA BONILLA SÁNCHEZ
and I. TOUME(1),
N. PIELENSTICKER(2)

(1)University Hospital Puerta de Hierro Majadahonda Community of Madrid, Spain
(2) Urgo GmbH, Sulzbach, Germany

Published in: Health & Medicine, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
470
On SlideShare
0
From Embeds
0
Number of Embeds
26
Actions
Shares
0
Downloads
5
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

EWMA 2013 - Ep566 - SEQUENTIAL TREATMENT OF CHRONIC WOUNDS WITH HYDRO-DESLOUGHING DRESSING* AND TLC-NOSF DRESSING*

  1. 1. SEQUENTIAL TREATMENT OF CHRONIC WOUNDS WITH HYDRO-DESLOUGHING DRESSING* AND TLC-NOSF DRESSING* T. SEGOVIA GÓMEZ, M. BERMEJO MARTINEZ, R. MA BONILLA SÁNCHEZ and I. TOUME(1), N. PIELENSTICKER(2) (1)University Hospital Puerta de Hierro Majadahonda Community of Madrid, Spain (2) Urgo GmbH, Sulzbach, Germany *Brand names: the hydro-desloughing dressing is UrgoClean® and the TLC-NOSF dressing is UrgoStart ®
  2. 2. INTRODUCTION The incidence of venous and arterial chronic wounds is a recognised type, as are the different phases that are required to complete a correct healing process so that the treatment of the wound is not prolonged. Carrying out desloughing and activating the granulation phase, followed by rapid, effective epithelialisation, are of vital importance because the products used for these functions must be specific and must also display evident efficacy. The new technologies applied to the wound bed, based on CAH/MET (moist environment treatment), in its different phases, now offer products which meet the needs of professionals for the different phases mentioned above by desloughing the wound bed and accelerating the healing process.
  3. 3. D0 Treatment with hydro-desloughing dressing* Integrated treatment with hydro-desloughing and TLC-NOSF dressings* 87 year-old patient referred to the General Surgery Department for evaluation and treatment of a vascular ulcer present for 4 months. Personal history Allergic to Aspirin Has worn a pacemaker since 1984 Anticoagulated with Sintron DESCRIPTION OF CASE 1 D45 Treatment with TLC-NOSF dressing* D72 Treatment with TLC-NOSF dressing* *Brand names: the hydro-desloughing dressing is UrgoClean® and the TLC-NOSF dressing is UrgoStart ®
  4. 4. Integrated treatment with hydro-desloughing dressing* 79 year-old patient referred to the UHC (Multidisciplinary Wounds Unit), Department of General Surgery, for valuation and treatment of vascular ulcers on the lower limbs. Personal history Arterial hypertension, positive hepatitis C virus, paroxystic articular fibrillation, Hypothyroidism, iron-deficiency anaemia, repeated pneumonia with home oxygen, Ex smoker and ex drinker. DESCRIPTION OF CASE 2 D0 D13 D80
  5. 5. Integrated treatment with TLC-NOSF dressing* 79 year-old woman. Referred from her health centre for assessment of an ulcer on the left knee, present for 15 days, following a trauma. Personal history No adverse drug reactions Arterial hypertension Nephrectomy due to malignant neoplasia. DESCRIPTION OF CASE 3 D0 D38 D52
  6. 6. Treatment with hydro-desloughing fibre dressings provided optimum preparation of the wound bed, which also facilitated the formation of granulation tissue. The dressing was characterised by excellent absorption and also facilitated removal of practically all the slough from the wound bed and contributed to desloughing totally atraumatic to the patient. The TLC-NOSF dressing* facilitates optimisation of granulation and epithelialisation phases, while providing the patient with totally atraumatic treatment in terms of dressing removal. The skin surrounding the wound was not affected either. CONCLUSION • Nelzen O, Bergqvist D, Lindhagen A. Venous and non-venous leg ulcers: clinical history and appearance in a population study. Br J Surg 1994;81:182–7.• Schultz GS, Sibbald RG, Falanga V, et al. Wound bed preparation: a systematic approach to wound management. Wound Repair Regen 2003; 11(2): Suppl S1-28.• Winter G. Formation of scab and the rate of epithelialisation of superficial wounds in the skin of the young domestic pig. Nature 1962; 193: 293-294.• Hinman CAMH. Effect of air exposure and occlusion on experimental human skin wounds. Nature 1963; 200: 377-378• Viennet C, Bride J, Gabiot AC, Humbert Ph. Comparison of different wound dressings on cultured human fibroblasts and collagen lattices. Journal of Wound Care. 2003. 12 (10): 385 – 390.• Schmutz JL, Meaume S, et al. Evaluation of the nano-oligosaccharide factor lipido- colloid matrix in the local management of venous leg ulcers: results of a randomised, controlled trial. Internatiol Wounds Journal. Vol 5 nº2. • Meaume, Sylvie et al. A randomized, controlled, doublé-blind prospective trial with a Lipido-Colloid Technology-Nano-OligoSaccharide Factor wound dressing in the local management of venous leg ulcers. Wound Repair and Regeneration. 2012. *Brand names: the hydro-desloughing dressing is UrgoClean® and the TLC-NOSF dressing is UrgoStart ®

×